Webinar: Development of New Drugs for Dementia - Current Status and Outlook

After decades of stagnating research, there's renewed momentum: new monoclonal antibodies against amyloid deposits, such as Lecanemab or Donanemab, are directly targeting the disease mechanisms of Alzheimer's dementia for the first time. Previous medications could only alleviate symptoms, but not slow the progression of the disease. How promising are the new drugs – and…

Webinar: Menopause and Cognitive Health

Hot flashes, sleep disturbances, mood swings – the menopausal phase can cause various physical and mental changes in women. Memory performance and other cognitive abilities, such as concentration and attention, can also be influenced by hormonal changes during this life stage. To alleviate the various symptoms of menopause, menopausal hormone replacement therapy can be used in...